Provided by Tiger Fintech (Singapore) Pte. Ltd.

Regeneron Pharmaceuticals

571.36
-2.8000-0.49%
Post-market: 572.901.54+0.27%19:55 EDT
Volume:1.66M
Turnover:953.31M
Market Cap:61.71B
PE:14.49
High:580.56
Open:576.35
Low:567.59
Close:574.16
Loading ...

Biotech stocks slide as Marks resignation seen being negative for sector

TipRanks
·
01 Apr

Regeneron Pharmaceuticals Inc : Leerink Partners Cuts Target Price to $780 From $834

THOMSON REUTERS
·
01 Apr

Regeneron Pharma Is Maintained at Overweight by JP Morgan

Dow Jones
·
31 Mar

Intellia Focuses on Pipeline Development Amid Stiff Competition

Zacks
·
31 Mar

Pharma Stocks Sink After Ouster of Top FDA Vaccine Regulator

Reuters
·
31 Mar

3 Stocks to Watch in the Evolving Cell-Based Ophthalmic Therapy Space

Zacks
·
31 Mar

JPMorgan Adjusts PT on Regeneron Pharmaceuticals to $1,000 From $1,100, Maintains Overweight Rating

MT Newswires Live
·
31 Mar

U.S. RESEARCH ROUNDUP- Braze, Home Bancshares, Union Pacific

Reuters
·
31 Mar

Regeneron (NASDAQ:REGN) and Sanofi Get Japan Green Light for Smokers’ Lung Disease Treatment

TIPRANKS
·
28 Mar

Press Release: Dupixent approved as the first-ever biologic medicine in Japan for patients with COPD

GlobeNewswire
·
28 Mar

Dupixent® (dupilumab) Approved as the First-ever Biologic Medicine in Japan for Patients with Chronic Obstructive Pulmonary Disease (COPD)

GlobeNewswire
·
28 Mar

Regeneron Pharmaceuticals Inc. Stock Slips 4.1%, Underperforms Competitors

Dow Jones
·
26 Mar

Press Release: Regeneron to Report First Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on April 29, 2025

Dow Jones
·
26 Mar

UBX Stock Down 29% on Mixed Results From Phase II Eye Disease Study

Zacks
·
25 Mar

Is Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) The Best Extremely Profitable Stocks to Buy According to Analyst?

Insider Monkey
·
25 Mar

BUZZ-Unity Biotechnology falls as eye disease treatment fails in mid-stage trial

Reuters
·
24 Mar

Regeneron Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
21 Mar

Natera (NASDAQ:NTRA) Q4 Earnings: Leading The Immuno-Oncology Pack

StockStory
·
20 Mar

Regeneron Pharmaceuticals (REGN): Among the Best Biotech Stocks to Buy According to Billionaires

Insider Monkey
·
18 Mar

Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
18 Mar